Qiagen Nv Earnings Preview: Get Ahead of the Analysts

Qiagen Nv (NASDAQ:QGEN) will report earnings after markets close on Monday, April 29th. QIAGEN N.V. provides sample and assay technologies. The Company’s technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Here is your Cheat Sheet to Qiagen Nv Earnings:

Earnings Expectations: Analysts expect earnings of $0.22 per share on revenues of $305.50 million. Currently, the company’s P/E ratio stands at 38.02.

Analyst Trends:

Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.26 and has not changed. For the current year, the average estimate is a profit of $1.1, which is the same as the estimate ninety days ago.

Earnings Trends:

Here’s how Qiagen Nv has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 892.98 1,010 1,087 1,170 1,254
Diluted EPS ($) 0.44 0.64 0.60 0.40 0.54

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 334.42 296.42 307.21 304.29 346.53
Diluted EPS ($) -0.01 0.12 0.14 0.12 0.16

Past Performance:
Qiagen Nv has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)

More Articles About:   , , , ,